Kodiak Sciences Inc (KOD) Financial Statements (2024 and earlier)

Company Profile

Business Address 1200 PAGE MILL RD
PALO ALTO, CA 94304
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments285,507,000478,933,000731,510,000968,974,000336,481,00088,254,000
Cash and cash equivalents285,507,000190,433,000731,510,000944,396,000211,797,00088,254,000
Short-term investments  288,500,000 24,578,000124,684,000 
Other undisclosed current assets3,802,0007,072,0003,301,0003,031,0002,749,0002,195,000
Total current assets:289,309,000486,005,000734,811,000972,005,000339,230,00090,449,000
Noncurrent Assets
Operating lease, right-of-use asset54,541,00059,369,00066,744,00073,672,0001,790,000
Property, plant and equipment120,482,00056,384,00041,330,0005,136,000996,0001,097,000
Long-term investments and receivables     11,696,000 
Long-term investments     11,696,000 
Restricted cash and investments6,324,0006,324,0006,324,0006,324,000140,000140,000
Other noncurrent assets8,716,00058,546,00055,011,00010,210,0005,014,000503,000
Total noncurrent assets:190,063,000180,623,000169,409,00095,342,00019,636,0001,740,000
TOTAL ASSETS:479,372,000666,628,000904,220,0001,067,347,000358,866,00092,189,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities31,959,00042,570,00060,750,00029,048,00011,277,0004,826,000
Accounts payable13,608,0009,130,00012,431,0008,646,0002,619,0001,050,000
Accrued liabilities18,351,00033,440,00048,319,00020,402,0008,658,0003,776,000
Debt     434,000 
Other undisclosed current liabilities9,770,0009,926,0003,933,0002,374,000  
Total current liabilities:41,729,00052,496,00064,683,00031,422,00011,711,0004,826,000
Noncurrent Liabilities
Long-term debt and lease obligation:   76,063,00075,028,0001,501,000 
Liabilities, other than long-term debt71,862,00077,969,000211,000256,000295,000530,000
Other liabilities  162,000211,000256,000295,000530,000
Operating lease, liability71,862,00077,807,00076,063,00075,028,0001,501,000
Other undisclosed noncurrent liabilities100,000,00099,996,00099,943,00099,890,000  
Total noncurrent liabilities:171,862,000177,965,000176,217,000175,174,0001,796,000530,000
Total liabilities:213,591,000230,461,000240,900,000206,596,00013,507,0005,356,000
Equity
Equity, attributable to parent265,781,000436,167,000663,320,000860,751,000345,359,00086,833,000
Common stock5,0005,0005,0005,0005,0004,000
Additional paid in capital1,418,307,0001,329,509,0001,221,532,0001,151,920,000503,475,000197,595,000
Accumulated other comprehensive income (loss)  (1,307,000) 53,00010,000 
Accumulated deficit(1,152,531,000)(892,040,000)(558,217,000)(291,227,000)(158,131,000)(110,766,000)
Total equity:265,781,000436,167,000663,320,000860,751,000345,359,00086,833,000
TOTAL LIABILITIES AND EQUITY:479,372,000666,628,000904,220,0001,067,347,000358,866,00092,189,000

Income Statement (P&L) (USD)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating expenses(277,321,000)(341,379,000)(267,051,000)(136,007,000)(49,190,000)(26,374,000)
Operating loss:(277,321,000)(341,379,000)(267,051,000)(136,007,000)(49,190,000)(26,374,000)
Nonoperating income (expense)16,943,0007,890,000(217,000)2,636,0001,833,000(4,371,000)
Investment income, nonoperating16,733,0007,687,000298,0002,902,0001,568,000 
Gain (loss), foreign currency transaction, before tax 100,000(300,000)(300,000)(300,000) (300,000)
Other nonoperating income (expense)110,000503,000(215,000)34,000265,000(4,071,000)
Interest and debt expense(13,000)(18,000)(22,000)(25,000)(8,000)(10,998,000)
Loss from continuing operations before equity method investments, income taxes:(260,391,000)(333,507,000)(267,290,000)(133,396,000)(47,365,000)(41,743,000)
Other undisclosed income from continuing operations before income taxes520,823,000667,297,000374,000314,000 300,000
Income (loss) from continuing operations before income taxes:260,432,000333,790,000(266,916,000)(133,082,000)(47,365,000)(41,443,000)
Income tax expense (33,000)(33,000)(74,000)(14,000)  
Other undisclosed loss from continuing operations      
Income (loss) from continuing operations:260,399,000333,757,000(266,990,000)(133,096,000)(47,365,000)(41,443,000)
Loss before gain (loss) on sale of properties:(266,990,000)(133,096,000)(47,365,000)(41,443,000)
Net income (loss):260,399,000333,757,000(266,990,000)(133,096,000)(47,365,000)(41,443,000)
Other undisclosed net loss attributable to parent(520,890,000)(667,580,000)    
Net loss available to common stockholders, diluted:(260,491,000)(333,823,000)(266,990,000)(133,096,000)(47,365,000)(41,443,000)

Comprehensive Income (USD)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):260,399,000333,757,000(266,990,000)(133,096,000)(47,365,000)(41,443,000)
Comprehensive income (loss):260,399,000333,757,000(266,990,000)(133,096,000)(47,365,000)(41,443,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(519,583,000)(668,887,000)(53,000)43,00010,000 
Comprehensive loss, net of tax, attributable to parent:(259,184,000)(335,130,000)(267,043,000)(133,053,000)(47,355,000)(41,443,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: